The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol Propionate 0.05%) cream

K.L. DALZIEL

Corresponding Author

Department of Dermatology, The slade Hospital, Oxford, U.K.

Dr K.L.Dalziel, Department of Dermatology, university Hospital, Queen's medical center, Nottingham NG7 2UH, U.K.
Search for more papers by this author
P.R. MILLARD

Department of Histopathology, John Radclife Hospital, Oxford, U.K.

Search for more papers by this author
F. WOJNAROWSKA

Department of Dermatology, The slade Hospital, Oxford, U.K.

Search for more papers by this author
First published: May 1991
Cited by: 101

Summary

The clinical and histological response to 12 weeks of treatment with a very potent topical fluorinated steroid was studied in 15 patients with vulval lichen sclerosus (LS) who were treated with twice eaily applications of clobetasol propionate 0.05% cream (Dermovate, Glaxo U.K.), Thirteen patients completed the study and all showed a marked clinical improvement. Histological measurements of skin biopsies taken before and after treatment showed a significant reduction in the characteristic features of LS. One patient developed contact sensitivity to clobetasol propionate. There was no evidence of infection or skin atrophy during the study. Patients completing the study have been followed up for up to 22 months and have been maintained in remission with moderately potent topical steroids which had previously been ineffective.

Number of times cited: 101

  • , Cushing Syndrome Induced by Topical Corticosteroids for the Treatment of Lichen Sclerosus, Journal of Pediatric and Adolescent Gynecology, 10.1016/j.jpag.2018.09.004, (2018).
  • , Development of the Adult Vulvar Lichen Sclerosus Severity Scale—A Delphi Consensus Exercise for Item Generation, Journal of Lower Genital Tract Disease, 10.1097/LGT.0000000000000361, 22, 1, (66-73), (2018).
  • , Evidence‐based (S3) guideline on (anogenital) lichen sclerosus. JEADV. 2015; 29(10):e1–e43, Journal of the European Academy of Dermatology and Venereology, 31, 1, (e57-e58), (2016).
  • , Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment, The Journal of Dermatology, 43, 9, (1078-1082), (2016).
  • , Diagnosis and Management of Male Genital Lichen Sclerosus, Current Bladder Dysfunction Reports, 10.1007/s11884-016-0375-2, 11, 3, (234-241), (2016).
  • , Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus, Journal of the European Academy of Dermatology and Venereology, 29, 10, (e1-e43), (2015).
  • , The Use of Specific Myofascial Release Techniques by a Physical Therapist to Treat Clitoral Phimosis and Dyspareunia, Journal of Womenʼs Health Physical Therapy, 39, 1, (17), (2015).
  • , Prepubertal‐Onset Vulvar Lichen Sclerosus: The Importance of Maintenance Therapy in Long‐Term Outcomes, Pediatric Dermatology, 32, 4, (461-467), (2015).
  • , Lichen Sclerosus and Lichen Planus in Women and Girls, Clinical Obstetrics and Gynecology, 58, 1, (125), (2015).
  • , Diagnosis and Treatment of Lichen Sclerosus, American Journal of Clinical Dermatology, 14, 1, (27), (2013).
  • , Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study, British Journal of Dermatology, 168, 6, (1316-1324), (2013).
  • , Randomized clinical trial on a hydrating intimate cleanser as an adjuvant in vulvar dermatosis therapy, Asian Pacific Journal of Reproduction, 2, 1, (42), (2013).
  • , Cutaneous Diseases of the External Genitalia, Campbell-Walsh Urology, 10.1016/B978-1-4160-6911-9.00015-3, (436-467.e7), (2012).
  • , Screening and follow up of vulval skin disorders, Best Practice & Research Clinical Obstetrics & Gynaecology, 26, 2, (175), (2012).
  • , Noninfectious Inflammatory Disorders of the Vulva, Diagnostic Gynecologic and Obstetric Pathology, 10.1016/B978-1-4377-0764-9.00002-0, (21-48), (2011).
  • , Inflammatory Dermatoses, British Association of Dermatologists' Management Guidelines, (1-90), (2011).
  • , Topical interventions for genital lichen sclerosus, Cochrane Database of Systematic Reviews, (2011).
  • , Benign disease of the vulva and the vagina, Gynaecology, 10.1016/B978-0-7020-3120-5.00040-0, (599-612), (2011).
  • , British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010, British Journal of Dermatology, 163, 4, (672-682), (2010).
  • , A New, Hydrodissection with Reverse V-Plasty Technique for the Buried Clitoris Associated with Lichen Sclerosus, Journal of Gynecologic Surgery, 26, 1, (41), (2010).
  • , Pharmacotherapy of Inflammatory and Pruritic Manifestations of Corticosteroid-Responsive Dermatoses Focus on Clobetasol Propionate, Clinical Medicine Insights: Therapeutics, 2, (CMT.S1993), (2010).
  • , The ‘Connective Tissue Diseases’, Rook's Textbook of Dermatology, (1-138), (2010).
  • , Long‐term management of vulval lichen sclerosus in adult women, Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, 2, (148-152), (2010).
  • , Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature, Journal of the European Academy of Dermatology and Venereology, 24, 7, (815-819), (2009).
  • , The effect of vulvar lichen sclerosus on quality of life and sexual functioning, Journal of Psychosomatic Obstetrics & Gynecology, 31, 4, (279), (2010).
  • , Paediatric vulval lichen sclerosus, Australasian Journal of Dermatology, 50, 4, (243-248), (2009).
  • , The Role of Calcineurin Inhibitors in the Management of Lichen Sclerosus, American Journal of Clinical Dermatology, 10, 5, (313), (2009).
  • , VULVAR AND VAGINAL PAIN, DYSPAREUNIA, AND ABNORMAL VAGINAL DISCHARGE, Female Urology, 10.1016/B978-1-4160-2339-5.50136-1, (857-876), (2008).
  • , The ‘Connective Tissue Diseases’, Rook's Textbook of Dermatology, (2697-2844), (2008).
  • , Review of squamous premalignant vulvar lesions, Critical Reviews in Oncology/Hematology, 10.1016/j.critrevonc.2008.02.012, 68, 2, (131-156), (2008).
  • , Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women, International Journal of Dermatology, 46, 5, (527-532), (2006).
  • , Successful treatment of vulvar lichen sclerosus in a child with low‐concentration topical tacrolimus ointment, The Journal of Dermatology, 34, 2, (114-116), (2007).
  • , Surgical treatment of clitoral phimosis caused by lichen sclerosus, American Journal of Obstetrics and Gynecology, 196, 2, (126.e1), (2007).
  • , Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus, British Journal of Dermatology, 155, 5, (1021-1028), (2006).
  • , Calcineurin antagonists in vulvar lichen sclerosus, Archives of Gynecology and Obstetrics, 274, 5, (266), (2006).
  • , Is carbon dioxide laser treatment of lichen sclerosus effective in the long run?, Scandinavian Journal of Urology and Nephrology, 40, 3, (208), (2006).
  • , Vulvar Disease Update, Advances in Dermatology, 22, (91), (2006).
  • , Lichen scléreux, EMC - Dermatologie, 1, 1, (1), (2006).
  • , Paediatric vulval disorders, Journal of Obstetrics and Gynaecology, 26, 7, (596), (2006).
  • , Vulvar Therapies, The Vulva, 10.1201/9781420005318-10, (115-150), (2013).
  • , An Overview of Lichen Sclerosus, Clinical Obstetrics and Gynecology, 48, 4, (808), (2005).
  • , Prurito, escozor y dolor vulvar: abordaje desde la atención primaria, FMC - Formación Médica Continuada en Atención Primaria, 12, 10, (654), (2005).
  • , The Association Between HLA DR, DQ Antigens, and Vulval Lichen Sclerosus in the UK: HLA DRB1*12 and its Associated DRB1*12/DQB1*0301/04/09/010 Haplotype Confers Susceptibility to Vulval Lichen Sclerosus, and HLA DRB1*0301/04 and its Associated DRB1*0301/04/DQB1*0201/02/03 Haplotype Protects from Vulval Lichen Sclerosus, Journal of Investigative Dermatology, 125, 5, (895), (2005).
  • , Lichen sclerosus, Der Hautarzt, 56, 6, (550), (2005).
  • , Successful Carbon Dioxide Laser Therapy for Refractory Anogenital Lichen Sclerosus, Dermatologic Surgery, 30, 8, (1148-1151), (2004).
  • , Lichen sclerosus: a review and practical approach, Dermatologic Therapy, 17, 1, (28-37), (2004).
  • , Liquen escleroso, EMC - Dermatología, 38, 1, (1), (2004).
  • , Lichen sclerosus in children, Journal of Obstetrics and Gynaecology, 24, 7, (733), (2004).
  • , Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl, Journal of Pediatric and Adolescent Gynecology, 17, 1, (35), (2004).
  • , Successful Carbon Dioxide Laser Therapy for Refractory Anogenital Lichen Sclerosus, Dermatologic Surgery, 30, 8, (1148), (2004).
  • , Tacrolimus ointment for the treatment of vulvar lichen sclerosus, Journal of the American Academy of Dermatology, 48, 6, (935), (2003).
  • , Comparación de clobetasol frente a prednicarbato para el tratamiento del prurito vulvar con o sin distrofia, Clínica e Investigación en Ginecología y Obstetricia, 30, 4, (104), (2003).
  • , Lichen sclerosus, Clinical and Experimental Dermatology, 28, 2, (128-133), (2003).
  • , Guidelines for the management of lichen sclerosus, British Journal of Dermatology, 147, 4, (640-649), (2002).
  • , Vulval Disease from the 1800s to the New Millennium, Journal of Cutaneous Medicine and Surgery, 6, 4, (340), (2002).
  • , Pruritus vulvae, Current Obstetrics & Gynaecology, 12, 4, (231), (2002).
  • , The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus, British Journal of Dermatology, 147, 3, (503-508), (2002).
  • , Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study, Journal of the American Academy of Dermatology, 46, 2, (251), (2002).
  • , Epidemiology and Precursors of Vulvar Cancer, Journal of Women's Imaging, 4, 3, (126), (2002).
  • , Lichen sclerosus and other conditions mimicking vulvovaginal candidiasis, Current Infectious Disease Reports, 4, 6, (520), (2002).
  • , Ulcers and erosions of the vulva, The Obstetrician & Gynaecologist, 3, 1, (32), (2001).
  • , Dermatology in gynaecology, Reviews in Gynaecological Practice, 1, 2, (70), (2001).
  • , Management of anogenital lichen sclerosus, Clinical and Experimental Dermatology, 26, 8, (637-643), (2008).
  • , Childhood vulvar lichen sclerosus: An increasingly common problem, Journal of the American Academy of Dermatology, 44, 5, (803), (2001).
  • , Clobetasol Propionate in the Treatment of Premenarchal Vulvar Lichen Sclerosus, Obstetrics & Gynecology, 98, 4, (588), (2001).
  • , THE RESPONSE OF BALANITIS XEROTICA OBLITERANS TO LOCAL STEROID APPLICATION COMPARED WITH PLACEBO IN CHILDREN, The Journal of Urology, 165, 1, (219), (2001).
  • , A clinical study of 23 cases of female anogenital carcinoma, British Journal of Dermatology, 143, 6, (1217-1223), (2001).
  • , Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: A retrospective clinical and histopathologic study, Journal of the American Academy of Dermatology, 40, 3, (451), (1999).
  • , Skin Ageing in Women: Pathophysiology and Treatment, British Menopause Society Journal, 5, 3, (111), (1999).
  • , Lichen sclerosus, The Lancet, 353, 9166, (1777), (1999).
  • , Photodynamic Therapy of Vulvar Lichen Sclerosus With 5-Aminolevulinic Acid, Obstetrics & Gynecology, 93, 1, (71), (1999).
  • , Lichen Sclerosus in Pregnancy: Presentation of Two Cases, Journal of Lower Genital Tract Disease, 3, 4, (260-263), (2001).
  • , Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus, American Journal of Obstetrics and Gynecology, 178, 1, (80), (1998).
  • , Vulvar dermatoses: Lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus, Seminars in Cutaneous Medicine and Surgery, 17, 3, (182), (1998).
  • , Vulval lichen sclerosus: lack of correlation between duration of clinical symptoms and histological appearances, Journal of the European Academy of Dermatology and Venereology, 8, 3, (212-216), (2006).
  • , Dermatologic diseases of the vulva, Clinics in Dermatology, 15, 1, (53), (1997).
  • , Treatment of lichen sclerosus with carbon dioxide laser vaporization, British Journal of Dermatology, 136, 3, (356), (1997).
  • , Treatment of Childhood Vulvar Lichen Sclerosus with Potent Topical Corticosteroid, Pediatric Dermatology, 14, 3, (235-238), (2008).
  • , Lichen sclerosus in women, Clinics in Dermatology, 15, 1, (155), (1997).
  • , The commonest causes of symptomatic vulvar disease: A dermatologist's perspective, Australasian Journal of Dermatology, 37, 1, (12-18), (2007).
  • , Vulval cicatricial pemphigoid may mimic lichen sclerosus, British Journal of Dermatology, 134, 3, (522), (1996).
  • , Lichen sclerosus, Seminars in Dermatology, 15, 1, (42), (1996).
  • , Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus, International Journal of Gynecology & Obstetrics, 55, 3, (259-264), (1999).
  • , ANDROGENS IN THE TOPICAL TREATMENT OF LICHEN SCLEROSUS, International Journal of Dermatology, 35, 4, (298-301), (2007).
  • , Surgical Treatment of Vulvar Lichen Sclerosus, Obstetrical & Gynecological Survey, 51, 3, (193), (1996).
  • , Treatment of vulvar dermatoses, Seminars in Dermatology, 15, 1, (71), (1996).
  • , Lichen sclerosus, Journal of the American Academy of Dermatology, 32, 3, (393), (1995).
  • , Treatment of Vulvar Lichen Sclerosus in the Elderly, Obstetrical & Gynecological Survey, 50, 2, (155), (1995).
  • , Lichen sclerosus in childhood, Australasian Journal of Dermatology, 36, 3, (166-167), (2007).
  • , Subdermal Decadron and Bupivacaine to Treat Symptomatic Lichen Sclerosus, Journal of Gynecologic Surgery, 11, 4, (245), (1995).
  • , Topical testosterone in the treatment of vulvar lichen sclerosus, International Journal of Gynecology & Obstetrics, 46, 1, (53-56), (2004).
  • , Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: A double-blind, placebo-controlled study, Journal of the American Academy of Dermatology, 30, 2, (225), (1994).
  • , The treatment of lichen sclerosus et atrophicus and squamous cell hyperplasia with graduated topical steroids, Journal of Obstetrics and Gynaecology, 14, 3, (172), (1994).
  • , Editorial: Clobetasol propionate: The ‘I wonder’ drug, Journal of Dermatological Treatment, 5, 1, (1), (1994).
  • , Nodular lichen sclerosus, Journal of the American Academy of Dermatology, 31, 5, (817), (1994).
  • , Vulvovaginal disease, Current Problems in Dermatology, 6, 6, (187), (1994).
  • , Clobetasol propionate 0·05% cream in the treatment of vulvar lichen sclerosus: effect on the immunohistological profile, British Journal of Dermatology, 127, 5, (542-543), (2006).
  • , Allergic contact dermatitis and vulvar dermatoses, British Journal of Dermatology, 126, 1, (52-56), (2006).
  • , Progress in recognition and management of vulval disease, Journal of Dermatological Treatment, 3, 2, (91), (1992).
  • , Topical interventions for genital lichen sclerosus, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD008240, (2010).
  • , Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment, Dermatologic Therapy, e12735, (2018).